Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Racial variations in quality of care and outcomes in an ambulatory heart failure cohort.

Deswal A, Petersen NJ, Urbauer DL, Wright SM, Beyth R.

Am Heart J. 2006 Aug;152(2):348-54.

PMID:
16875921
2.

Racial differences in responses to drug treatment: implications for pharmacotherapy of heart failure.

Taylor JS, Ellis GR.

Am J Cardiovasc Drugs. 2002;2(6):389-99. Review.

PMID:
14727954
3.

Relationship between race and mortality and morbidity after valve replacement surgery.

Taylor NE, O'Brien S, Edwards FH, Peterson ED, Bridges CR.

Circulation. 2005 Mar 15;111(10):1305-12. Review.

4.

How well are chronic heart failure patients being managed?

Fonarow GC.

Rev Cardiovasc Med. 2006;7 Suppl 1:S3-11. Review.

PMID:
16955055
5.

The prevention of heart failure in minority communities and discrepancies in health care delivery systems.

Yancy CW.

Med Clin North Am. 2004 Sep;88(5):1347-68, xii-xiii. Review.

PMID:
15331320
6.

Racial differences in prostate cancer treatment outcomes: a systematic review.

Peters N, Armstrong K.

Cancer Nurs. 2005 Mar-Apr;28(2):108-18. Review.

PMID:
15815180
7.

Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.

Fonarow GC, Gheorghiade M, Abraham WT.

Am J Cardiol. 2004 Nov 1;94(9):1155-60. Review.

PMID:
15518610
8.

[Hypertension in the Negro patient].

Timmers GJ, Schouten JA, ter Wee PM, Gans RO.

Ned Tijdschr Geneeskd. 1999 Jan 30;143(5):229-34. Review. Dutch.

PMID:
10086150
9.

Heart failure management in African Americans: meeting the challenge.

Durand JB.

J Clin Hypertens (Greenwich). 2004 Apr;6(4 Suppl 1):42-7. Review.

10.

The impact of race on response to RAAS inhibition.

Wallace TW, Drazner MH.

Curr Heart Fail Rep. 2005 Aug;2(2):72-7. Review.

PMID:
16036054
11.

Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.

Regitz-Zagrosek V, Lehmkuhl E.

Herz. 2005 Aug;30(5):356-67. Review. English, German.

PMID:
16132238
12.

Racial response to angiotensin-converting enzyme therapy in systolic heart failure.

Dries DJ, Yancy CW, Strong MA, Drazner MH.

Congest Heart Fail. 2004 Jan-Feb;10(1):30-3. Review.

14.

Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position.

Ferdinand KC, Serrano CC, Ferdinand DP.

Curr Hypertens Rep. 2002 Aug;4(4):311-8. Review.

PMID:
12117459
16.

The role of race in heart failure therapy.

Yancy CW.

Curr Cardiol Rep. 2002 May;4(3):218-25. Review.

PMID:
11960591
17.

Therapies to prevent heart failure post-myocardial infarction.

Thomas KL, Velazquez EJ.

Curr Heart Fail Rep. 2005 Dec;2(4):174-82. Review.

PMID:
16332310
18.

Is heart failure in African Americans a distinct entity?

Scott RL.

Congest Heart Fail. 2003 Jul-Aug;9(4):193-6. Review.

19.

Heart failure in African Americans: pathophysiology and treatment.

Yancy CW.

J Card Fail. 2003 Oct;9(5 Suppl Nitric Oxide):S210-5. Review. No abstract available.

PMID:
14583891
20.

Hypertension in minorities: blacks.

Saunders E.

Am J Hypertens. 1995 Dec;8(12 Pt 2):115s-119s. Review.

PMID:
8845094

Supplemental Content

Support Center